Adverse events ‐ ovarian cyst · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ ovarian cyst compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects: headache · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ headache compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ migraine · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ migraine compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ depression · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ depression compared with placebo (very low certainty).
1 finding from 1 review
Overall Survival** · locally advanced or metastatic breast cancer
PARPi‐containing regimen showed no clear difference in overall Survival** compared with non‐PARPi regimen (high certainty).
1 finding from 1 review
Progression‐free survival · locally advanced or metastatic breast cancer
PARPi‐containing regimen leads to lower progression Free Survival** compared with non‐PARPi regimen (high certainty).
1 finding from 1 review
Response rate · locally advanced or metastatic breast cancer
PARPi‐containing regimen may leads to higher response Rate compared with non‐PARPi regimen (low certainty).
1 finding from 1 review
Grade ≥3 AEs · locally advanced or metastatic breast cancer
PARPi‐containing regimen showed no clear difference in grade ≥3 AEs compared with non‐PARPi regimen (moderate certainty).
1 finding from 1 review
Event‐free survival · children, adolescents, and young adults with primary metastatic Ewing sarcoma
High‐dose chemotherapy followed by autologous haematopoietic cell… showed no clear difference in event‐free survival (reported as number of participants with… compared with conventional chemotherapy plus whole lung irradiation (low certainty).
1 finding from 1 review
Overall survival · children, adolescents, and young adults with primary metastatic Ewing sarcoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality‐adjusted survival · children, adolescents, and young adults with primary metastatic Ewing sarcoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Toxicity · children, adolescents, and young adults with primary metastatic Ewing sarcoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Progression‐free survival · children, adolescents, and young adults with primary metastatic Ewing sarcoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quantity of service provision ‐ number of outpatients visits, specialist visits, or hospitalisations · healthcare providers working in outpatient healthcare settings
1 finding from 1 review
Service quality · healthcare providers working in outpatient healthcare settings
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient outcomes ‐ people with mental illness · healthcare providers working in outpatient healthcare settings
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Very low
Healthcare provider outcomes (such as work morale or workload) · healthcare providers working in outpatient healthcare settings
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Costs · healthcare providers working in outpatient healthcare settings
1 finding from 1 review
no estimate extracted
2 participants
Very low
Unintended or adverse effects · healthcare providers working in outpatient healthcare settings
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Low
Interventions (corticosteroids included in all regimens)a · adult cancer patients at risk for CINV caused by highly emetogenic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found